Vaccine effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca to prevent severe COVID-19 in Costa Rica by September and October 2021: A nationwide, observational study of hospitalisations prevalence

Luis Rosero-Bixby
doi: https://doi.org/10.1101/2021.11.08.21266087

Article Information

doi 
https://doi.org/10.1101/2021.11.08.21266087
History 
  • November 9, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Luis Rosero-Bixby, Emeritus Professor*
  1. Universidad de Costa Rica, Centro Centroamericano de Población (CCP)
  1. ↵* Corresponding author; email: lrosero{at}me.com
Back to top
Posted November 09, 2021.
Download PDF
Data/Code
Email
Vaccine effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca to prevent severe COVID-19 in Costa Rica by September and October 2021: A nationwide, observational study of hospitalisations prevalence
Luis Rosero-Bixby
medRxiv 2021.11.08.21266087; doi: https://doi.org/10.1101/2021.11.08.21266087
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area